Clinical Trial
Study Details
Sickle cell patients who need a new vein puncture in order to infuse them will benefit of AccuveinV400 device to illuminate their venous network
In the control group, the nurse proceeds as usual to infuse the patient (visual identification in the light of the chamber and palpation)
The primary goal of this randomized, controlled, open-label study is to determine the efficacy of AccuveinV400 (a transillumination veins device) to facilitate peripheral intravenous (IVP) catheter placement during a vaso-oclusive crisis. The investigators hypothesized that the number of attempts to a successful placement of a peripheral IV, our primary outcome, would be shorter with the assistance of the Accuvein V400. It is also expected that AccuveinV400 will reduce the time of the procedure, the rate of failure, the technique-related pain.
Study Overview
Contacts and Locations
CHU H. Mondor
Créteil
France
AP-HP - Hopital Europeen Georges-Pompidou Paris, France
75908 Paris
France